Login
Register
Submit a Paper
Propose a Special lssue
Open Access
HOW I DO IT
Intradetrusor onabotulinumtoxinA injection: how I do it
Department of Urology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA
Address correspondence to Dr. Patrick J. Shenot, Department
of Urology, Thomas Jefferson University, 1025 Walnut Street,
Suite 1112, Philadelphia, PA 19107 USA
Canadian Journal of Urology 2013, 20(1), 6649-6655.
Download PDFAbstract
Overactive bladder is a highly prevalent condition that may have significant impact on quality of life. This condition may be idiopathic or may have a neurogenic etiology. Antimuscarinics have long been the preferred agents for the treatment of this condition. OnabotulinumtoxinA, an injectible agent that prevents presynaptic release of acetylcholine at the neuromuscular junction, has emerged as an important option in the management of patients with urinary incontinence caused by refractory detrusor overactivity. This manuscript describes our technique for performing utilizing this therapy, describes key equipment needed and provides technical tips for avoiding common pitfalls.Keywords
overactive bladder, urinary incontinence, onabotulinumtoxinA
Cite This Article
APA Style
Shenot, P.J., Mark, J.R. (2013). Intradetrusor onabotulinumtoxinA injection: how I do it. Canadian Journal of Urology, 20(1), 6649–6655.
Vancouver Style
Shenot PJ, Mark JR. Intradetrusor onabotulinumtoxinA injection: how I do it. Can J Urology. 2013;20(1):6649–6655.
IEEE Style
P.J. Shenot and J.R. Mark, “Intradetrusor onabotulinumtoxinA injection: how I do it,” Can. J. Urology, vol. 20, no. 1, pp. 6649–6655, 2013.
Copyright © 2013 The Author(s). Published by Tech Science Press.This work is licensed under a Creative Commons Attribution 4.0 International License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Downloads
Citation Tools
